Mobile

A Open-Label, Parallel-Group, Exploratory Study to Evaluate the Efficacy and Safety of 400 µg Regadenoson Bolus for Pharmacological Stress Echocardiography

Mise à jour : Il y a 4 ans
Référence : EUCTR2008-003839-20

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

To evaluate the efficacy of a 400 µg regadenoson bolus for pharmacological stress echocardiography by comparing the stress echocardiographic images obtained after dobutamine with those obtained after regadenoson alone, regadenoson with low-level exercise (25W), regadenoson with echocontrast agent, and by comparing PSE images obtained after dipyridamole with those obtained after regadenoson.

Critère d'inclusion

  • Suspected coronary artery disease

Liens